CATALENT, INC. |
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 56.24 USD | -0.27% |
|
+3.61% | +25.17% |
| May. 29 | Catalent Shareholders Approve Deal With Novo Holdings | MT |
| May. 29 | Catalent stockholders approve deal with Novo Holdings | RE |
ETFs positioned on Catalent, Inc.
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 1.35% | 2 M€ | -.--% | ||
| 1.21% | 7 M€ | +5.53% | ||
| 0.83% | 2 M€ | +9.08% | ||
| 0.60% | 21 M€ | +7.83% | - | |
| 0.48% | 7 M€ | -.--% | - | |
| 0.40% | 92 M€ | +0.06% | - | |
| 0.22% | 9 M€ | -.--% | - | |
| 0.21% | 8 M€ | +4.93% | - | |
| 0.21% | 31 M€ | +0.05% | - | |
| 0.21% | 20 M€ | +4.74% | - | |
| 0.09% | 2,334 M€ | +16.63% | ||
| 0.08% | 5 M€ | -72.95% | - | |
| 0.07% | 9 M€ | +7.98% | - | |
| 0.07% | 825 M€ | +11.11% | ||
| 0.06% | 261 M€ | -.--% | - | |
| 0.06% | 200 M€ | +11.72% | - | |
| 0.06% | 488 M€ | +14.78% | ||
| 0.05% | 26 M€ | +24.50% | - | |
| 0.05% | 2,567 M€ | +15.32% | - | |
| 0.04% | 36 M€ | +22.19% | ||
| 0.04% | 288 M€ | +21.94% | ||
| 0.04% | 61 M€ | +24.01% | - | |
| 0.03% | 276 M€ | +11.40% | - | |
| 0.03% | 0 M€ | 0.00% | - |
Catalent, Inc. is specialized in pharmaceutical outsourcing services. The group offers solutions for the development and formulation of drugs, biological products and animal health products. Net sales break down by activity as follows:
- provision of development services and clinical supply services (55.4%);
- subcontracted manufacturing services (44.6%).
Net sales are distributed geographically as follows: the United States (63.2%), Europe (28.7%) and other (8.1%).
Sector
Pharmaceuticals
Calendar
2024-08-26
- Q4 2024 Earnings Release (Projected)
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
C
Sell
Buy
Mean consensus
HOLD
Number of Analysts
9
Last Close Price
56.39
USD
Average target price
63.5
USD
Spread / Average Target
+12.61%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +25.17% | 10.21B | |
| +49.29% | 765B | |
| -6.21% | 354B | |
| +20.52% | 331B | |
| +9.87% | 299B | |
| +18.87% | 248B | |
| -1.96% | 219B | |
| +11.11% | 216B | |
| +5.39% | 164B | |
| -2.52% | 162B |
- Stock Market
- Equities
- CTLT Stock
- Funds and ETFs Catalent, Inc.
